Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 11mg equivalent to 2.2 mg nicotine and incl. overage;  ;   - chewing gum - 2 mg - active: nicotine polacrilex 11mg equivalent to 2.2 mg nicotine and incl. overage     excipient: acacia acesulfame potassium cafosa 258 soft carnauba wax levomenthol light magnesium oxide peppermint oil   purified water sodium bicarbonate sodium carbonate titanium dioxide xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 22mg equivalent to 4.4 mg nicotine and incl. overage;  ;   - chewing gum - 4 mg - active: nicotine polacrilex 22mg equivalent to 4.4 mg nicotine and incl. overage     excipient: acacia acesulfame potassium cafosa 258 soft carnauba wax levomenthol light magnesium oxide peppermint oil   purified water quinoline yellow   sodium carbonate titanium dioxide xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 10mg equivalent to to 2 mg nicotine;  ;   - chewing gum - 2 mg - active: nicotine polacrilex 10mg equivalent to to 2 mg nicotine     excipient: cafosa 257 classic flavour for smoker 84.6422 glycerol menthol flavour zd49284 sodium bicarbonate sodium carbonate sorbitol - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 20mg equivalent to to 4 mg nicotine;  ;   - chewing gum - 4 mg - active: nicotine polacrilex 20mg equivalent to to 4 mg nicotine     excipient: cafosa 257 classic flavour for smoker 84.6422 glycerol menthol flavour zd49284 quinoline yellow sodium carbonate sorbitol - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 10mg equivalent to 2 mg nicotine. plus 10% overage;  ;   - chewing gum - 2 mg - active: nicotine polacrilex 10mg equivalent to 2 mg nicotine. plus 10% overage     excipient: acesulfame potassium cafosa 258 soft carnauba wax hypromellose levomenthol magnesium oxide peppermint oil polysorbate 80 sodium bicarbonate sodium carbonate starch sucralose titanium dioxide winterfresh flavour rde4-149 0488110 xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 20mg equivalent to 4 mg nicotine. plus 10% overage;  ;   - chewing gum - 4 mg - active: nicotine polacrilex 20mg equivalent to 4 mg nicotine. plus 10% overage     excipient: acesulfame potassium cafosa 258 soft carnauba wax hypromellose levomenthol magnesium oxide peppermint oil polysorbate 80 quinoline yellow sodium carbonate starch sucralose titanium dioxide winterfresh flavour rde4-149 0488110 xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 10mg equivalent to 2 mg nicotine;  ;   - chewing gum - 2 mg - active: nicotine polacrilex 10mg equivalent to 2 mg nicotine     excipient: cafosa 257 classic flavour for smoker 84.6422 glycerol sorbitol 70% menthol flavour zd49284 sodium bicarbonate sodium carbonate sorbitol

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 20mg equivalent to 4 mg nicotine;  ;   - chewing gum - 4 mg - active: nicotine polacrilex 20mg equivalent to 4 mg nicotine     excipient: cafosa 257 classic flavour for smoker 84.6422 glycerol menthol flavour zd49284 quinoline yellow sodium carbonate sorbitol  

Singapúr - enska - HSA (Health Sciences Authority)

gsk consumer healthcare singapore pte. ltd. - nicotine polacrilin eqv nicotine - gum, chewing - 2 mg - nicotine polacrilin eqv nicotine 2 mg

Singapúr - enska - HSA (Health Sciences Authority)

gsk consumer healthcare singapore pte. ltd. - nicotine polacrilin eqv nicotine - gum, chewing - 4 mg - nicotine polacrilin eqv nicotine 4 mg